Medco Health Solutions 2004 Drug Trend Report has revealed eye-opening data about medication spending to treat behavioral disorders in pediatric patients. Specifically, spending on drugs primarily used to treat attention-deficit/hyperactivity disorder skyrocketed by 369% for children under age 5. The number of children taking 1 or more prescription medications to treat behavior-related conditions hit almost 9% for those children taking at least 1 medication overall. Other significant findings of the analysis are as follows:
Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.
Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?
Clinical features with downloadable PDFs